Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components

Table 5 Total Costs per Category (values in Euros (€)

Cost Category	V/A/H	V/H	A/V	A/H
Drugs	6863.94	4464.02	5760.68	2206.07
Other Medication	1732.86	1733.97	1773.32	1690.92
Hospitalisation	2567.05	2613.56	2621.59	2560.13
Outpatient Visits	400.32	402.42	403.43	394.44
Vascular Interventions	1818.07	1779.99	1785.88	1743.21
Laboratory Exams	2572.37	2552.66	2558.97	2501.37
Death	570.62	578.11	576.59	593.94
Total Cost^a	16,525.25	14,124.74	15,480.46	11,690.08

^aAdding up the values for each combination might differ from the total cost value due to rounding

ISSN: 1478-7547